These findings (Fig. 2D) suggest that proteolysis of mTOR protein most likely contributes to the lowering the level of this protein in the noncancerous breast cells, but this degradation process is, most likely, less effective in the breast cancer cells. Here, MTOR is linked to breast carcinoma.